26.3 A CUSTOMIZED ADHERENCE ENHANCEMENT PROGRAM COMBINED WITH LONG-ACTING INJECTABLE ANTIPSYCHOTIC MEDICATION (CAE-L) FOR POORLY ADHERENT PATIENTS WITH CHRONIC PSYCHOTIC DISORDER IN TANZANIA

Chronic psychotic disorders (CPDs), such as schizophrenia, occur world-wide and cause significant burden characterized by reduced quality of life, functional impairment and premature mortality due to suicide and other causes. Care for CPD includes both psychosocial and pharmacologic interventions (i.e. antipsychotic drugs) along with ongoing monitoring of health status. This may be challenging in resource-limited settings where staff are sparse...